New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices

NEW MR-CONDITIONAL LABELING FOR TWO OF THE COMPANY'S MOST WIDELY-USED HIGH VOLTAGE DEVICES CONTINUE CADENCE OF MRI APPROVALS WITHIN ABBOTT'S CARDIAC RHYTHM MANAGEMENT PORTFOLIO ABBOTT PARK, Ill., Jan. 3, 2018 -- (Healthcare Sales & Marketing Network) -... Devices, Cardiology, Radiology, FDA Abbott, Quadra Assura, CRT-D, ICD, magnetic resonance imaging
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news